INVS

Across TCGA pan-cancer cohorts, INVS mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated INVS data layer compared with 23 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher INVS mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated INVS expression acts as an unfavorable survival marker, although some lineages such as LUAD and CCRCC show a favorable association.

LUAD and CCRCC are the cancer types where INVS mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	III,IV	0.922	0.409	.024	6	view →
CCRCC	OS	Tertile	All	1.000	0.585	.027	5	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

INVS–LUAD (DFS)

Open the LUAD breakdown →